788P - A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

Autor: Hosoda, K., Azuma, M., Katada, C., Ishido, K., Niihara, M., Ushiku, H., Sakuraya, M., Washio, M., Wada, T., Watanabe, A., Harada, H., Tanabe, S., Koizumi, W., Yamashita, K., Hiki, N., Watanabe, M.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v303-v303
Databáze: ScienceDirect